Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medications to prevent tooth whitening sensitivity
RBR-9gxbg6Phase 3Completed
- Sponsor
- Unioeste
- Start
- Jan 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of potassium nitrate, sodium fluoride, ketorolac, acetaminophen, vitamin e and 1 more in Dentinal hypersensitivity (DH) and Dental stain (10 arms), sponsored by Unioeste. Started Jan 2016; status: completed.
02
Drugs
potassium nitratesodium fluorideketorolacacetaminophenvitamin e
03
Conditions
Dentinal hypersensitivity (DH)Dental stain
Beyond the preview
Go deeper on RBR-9gxbg6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9gxbg6.